Dr. David K. Zielke, MD

Dr. Zielke practices at Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium.

Dr. Zielke's NPI, 1063822831, was assigned on May 2, 2014. Dr. Zielke graduated from State University of NY Upstate Medical University in 2014. Dr. Zielke holds Alaska license 162620.

Dr. Zielke's primary practice is Alaska Native Medical Center, at 4315 Diplomacy Dr, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 563-2662.

Dr. Zielke's primary practice is Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium. The medical group on file is Alaska Native Medical Center. Dr. Zielke's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zielke practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Zielke's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Zielke is licensed in Alaska.

CMS data shows 406 Medicare services from Dr. Zielke across 11 procedure codes in 2024, for 177 Medicare patients. Medicare paid $45,458 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 177 Medicare patients who saw Dr. Zielke in 2024. The largest group is 65 to 74, with 85 patients. 71% of them have high blood pressure, and 64% have copd. 63% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zielke's median patient age at 71, with 62% women.

In 2024, Dr. Zielke wrote 46 Medicare Part D claims for 25 patients. 48% of them were for generic drugs. CMS names the drug for 40 of them, across 3 drugs with 11 or more claims each, at $8,967 in total drug cost. In 2022, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Zielke for performance year 2024, reported as part of a group. Dr. Zielke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zielke as offering telehealth.

CMS Open Payments shows 3 general payments to Dr. Zielke from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Ethicon Inc. paid the most, $99.

Dr. Zielke graduated from State University of NY Upstate Medical University in 2014.